搜期刊
刊名

文献信息

  • 任意字段
  • 主题词
  • 篇关摘
  • 篇名
  • 关键词
  • 摘要
  • 作者
  • 第一作者
  • 作者单位
  • 刊名
  • 中图分类号
  • 学科分类号
  • DOI
  • 基金

Journal of Ocular Pharmacology and Therapeutics 中科院4区 JCR:Q3 JCR:Q2 SCIE CA PubMed JST
发文量 3,099
被引量 57,990
影响因子(2025版) 2.439

Journal of Ocular Pharmacology and Therapeutics is the only peer-reviewed journal that combines the fields of ophthalmology and pharmacology to enable optimal treatment and prevention of ocular diseases and disorders. The Journal delivers the latest discoveries in the pharmacokinetics and pharmacodynamics of therapeutics for the treatment of ophthalmic disorders. Journal of Ocular Pharmacology and Therapeutics coverage includes: Glaucoma Cataracts Retinal degeneration Ocular infection, trauma, and toxicology Ocular drug delivery and biotransformation Ocular pharmacotherapy/clinical trials Ocular inflammatory and immune disorders Gene and cell-based therapies Ocular metabolic disorders Ocular ischemia and blood flow Proliferative disorders of the eye Eyes on Drug Discovery - written by Gary D. Novack, PhD, featuring the latest updates on drug and device pipeline developments as well as policy/regulatory changes by the FDA.

  • 主办单位: MARY ANN LIEBERT, INC
  • 出版地区: NEW ROCHELLE
  • 出版周期: 月刊
  • 别名: J OCUL PHARMACOL TH;J. Ocular Pharmacol. Ther.;Journal of Ocular Pharmacology & Therapeutics;JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS;眼科药理学与治疗学杂志
  • 国际标准连续出版物号/电子版 ISSN 1080-7683 / EISSN 1557-7732
  • 创刊时间: 1995年
  • 曾用名: Journal of ocular pharmacology
收录汇总 栏目浏览 期刊详情
收录汇总
出版文献
期刊详情
新发布(2025版)
分析评价

期刊信息

  • 主办单位:MARY ANN LIEBERT, INC
  • 地  址: NEW ROCHELLE

期刊简介

Journal of Ocular Pharmacology and Therapeutics is the only peer-reviewed journal that combines the fields of ophthalmology and pharmacology to enable optimal treatment and prevention of ocular diseases and disorders. The Journal delivers the latest discoveries in the pharmacokinetics and pharmacodynamics of therapeutics for the treatment of ophthalmic disorders. Journal of Ocular Pharmacology and Therapeutics coverage includes: Glaucoma Cataracts Retinal degeneration Ocular infection, trauma, and toxicology Ocular drug delivery and biotransformation Ocular pharmacotherapy/clinical trials Ocular inflammatory and immune disorders Gene and cell-based therapies Ocular metabolic disorders Ocular ischemia and blood flow Proliferative disorders of the eye Eyes on Drug Discovery - written by Gary D. Novack, PhD, featuring the latest updates on drug and device pipeline developments as well as policy/regulatory changes by the FDA.